Skip to main content
. 2019 May 8;10:424. doi: 10.3389/fgene.2019.00424

Table 2.

Genes exhibiting different somatic mutation rates in African American (AA) and Caucasian American (CA) patients with multiple myeloma.

Gene symbol Gene name Mutated in AA (%) Mutated in CA (%) AA vs CA ratio p value
ABI3BP ABI family member 3 binding protein 3.9 1.0 3.9 0.015
ANKRD26 Ankyrin repeat domain 26 3.1 0.2 16 <10-3
AUTS2 Activator of transcription and developmental regulator 3.9 1.2 3.3 0.028
BCL7A BCL tumor suppressor 7A 3.9 0.8 4.9 0.007
BRWD3 Bromodomain and WD repeat domain containing 3 3.9 0.8 4.9 0.007
DDX17 DAED-box helicase 17 3.1 0.7 4.4 0.016
GRM7 Glutamate metabotropic receptor 7 3.9 1.0 3.9 0.015
IRF4 Interferon regulatory factor 4 ND 3.2 N/A 0.041
MYH13 Myosin heavy chain 13 3.9 0.8 4.9 0.007
PARP4 Poly(ADP-ribose) polymerase family member 4 3.9 1.0 3.9 0.015
PLD1 Phospholipase D1 3.1 0.3 10 0.002
PTCHD3 Patched domain containing 3 4.7 1.0 4.7 0.003
RPL10 Ribosomal protein 10 4.7 1.0 4.7 0.003
RYR1 Ryanodine receptor 1 9.4 4.9 1.9 0.045
SPEF2 Sperm flagellar 2 3.9 0.8 4.9 0.001
STXBP4 Syntaxin binding protein 4 3.1 ND N/A <10-3
TP53 Tumor protein p53 1.6 6.3 0.25 0.035